On the other hand, heart-specific overexpression of ANT1 has distinctive cardioprotective effects in various experimental heart diseases, such as hypertension-induced hypertrophic cardiomyopathy, as well as diabetic or ischemic heart disease [8,9,10]. This evidence concerns the gene SLC25A4 and hypertrophic cardiomyopathy.